Role of peroxisome proliferator-activated receptor-gamma (PPARγ) during liver regeneration in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 6, 2008, Pages 930-937

  Yamamoto, Yoshio ^a   Ono, Takashi ^a   Dhar, Dipok Kumar ^a   Yamanoi, Akira ^a   Tachibana, Mitsuo ^a   Tanaka, Tsuneo ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

15 deoxy 12,14 prostaglandin J2 (15d PGJ2); Hepatocyte; Liver regeneration; Peroxisome proliferator activated receptor gamma (PPAR ); Pioglitazone

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 44949102554     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05370.x     Document Type: Article

References (33)

1. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear-receptor signaling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 1996 12: 335 63.
2. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999 354: 141 8.
3. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994 79: 1147 56.
4. Yu S, Matsusue K, Kashireddy P et al. Adipocyte-specific gene expression and adipogenic steatosis in the liver due to peroxisome proliferator-activated receptor gamma1 over expression. J. Biol. Chem. 2003 278: 498 505.
5. Davies GF, Khandelwal RL, Roesler WJ. Troglitazone induces expression of PPARgamma in liver. Mol. Cell. Biol. Res. Commun. 1999 2: 202 8.
6. Sarraf P, Mueller E, Jones D et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat. Med. 1998 4: 1046 52.
7. Forman BM, Samuels HH. Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol. Endocrinol. 1990 4: 1293 301.
8. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995 83: 803 12.
9. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995 83: 813 19.
10. Cheng J, Nakamura H, Imanishi H et al. Peroxisome proliferator-activated receptor γ ligands, 15-deoxy-Δ12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. Biochem. Biophys. Res. Commun. 2004 322: 458 64.
11. Rocchi S, Auwerx J. Peroxisome proliferator-activated receptorγ: a versatile metabolic regulator. Ann. Med. 1999 31: 342 51.
12. Everett L, Galli A, Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver 2000 20: 191 9.
13. Quraishi O, Mancini JA, Riendeau D. Inhibition of inducible prostaglandin E2 synthase by 15-deoxy-Δ12,14-prostaglandin J2 and polyunsaturated fatty acids. Biochem. Pharmacol. 2002 63: 1183 9.
14. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998 391: 79 82.
15. Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem. Biophys. Res. Commun. 2004 315: 187 95.
16. Motomura W, Takahashi N, Nagamine M et al. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Int. J. Cancer 2004 108: 41 6.
17. Rumi M, Sato H, Ishihara S et al. Peroxisome proliferator-activated receptor gamma ligand induced growth inhibition of human hepatocellular carcinoma. Br. J. Cancer 2001 84: 1640 7.
18. Toyoda M, Takagi H, Horiguchi N et al. A ligand for peroxisome proliferator-activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Gut 2002 50: 563 7.
19. Galli A, Ceni E, Crabb DW et al. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARγ independent mechanisms. Gut 2004 53: 1688 97.
20. Chen A, Xu J. Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am. J. Physiol. Gastrointest. Liver Physiol. 2005 288: G447 56.
21. Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995 9: 1527 36.
22. Zimmermann A. Regulation of liver regeneration. Nephrol. Dial. Transplant. 2004 19: 6 10.
23. Starkel P, Saeger CD, Sempoux C, Legrand E, Leclercq I, Horsmans Y. Blunted DNA synthesis and delayed S-phase entry following inhibition of Cdk2 activity in the regenerating rat liver. Lab. Invest. 2005 85: 562 71.
24. Jakowlew SB, Mead JE, Danielpour D, Wu J, Roberts AB, Fausto N. Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. Cell. Regul. 1991 2: 535 48.
25. Date M, Matsuzaki K, Matsushita M, Tahashi Y, Sakitani K, Inoue K. Differential regulation of activin A for hepatocyte growth and fibronection synthesis in rat liver injury. J. Hepatol. 2000 32: 251 60.
26. Ueda S, Yamanoi A, Hishikawa Y, Dhar DK, Tachibana M, Nagasue N. Transforming growth factor-bata1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab. Invest. 2003 83: 1595 603.
27. Galli A, Crabb DW, Ceni E et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002 122: 1924 40.
28. Higgins GM, Anderson RM. Experimental pathology of the liver. Arch. Pathol. 1931 12: 186 202.
29. Suh N, Wang Y, Williams CR et al. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Res. 1999 59: 5671 3.
30. Jiang WG, Douglas-Jones A, Mansel RE. Expression of peroxisome- proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int. J. Cancer 2003 106: 752 7.
31. Yu J, Qiano L, Zimmermann L et al. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology 2006 43: 134 43.
32. Turmelle YP, Shikapwashya O, Tu S, Hruz PW, Yan Q, Rudnick SA. Rosiglitazone inhibits mouse liver regeneration. FASEB J 2006 20: 2609 11.
33. Fausto N. Liver regeneration. J. Hepatol. 2000 32 (Suppl 1 19 31.